Recommended Topic Related To:

GlucaGen

"On Feb. 24, 2014, the U.S. Food and Drug Administration approved Myalept (metreleptin for injection) as replacement therapy to treat the complications of leptin deficiency, in addition to diet, in patients with congenital generalized or acquired "...

GlucaGen

INDICATIONS

Treatment of severe hypoglycemia

GlucaGen is used to treat severe hypoglycemic (low blood sugar) reactions which may occur in patients with diabetes mellitus treated with insulin. Because GlucaGen depletes glycogen stores, the patient should be given supplemental carbohydrates as soon as he/she awakens and is able to swallow, especially children or adolescents. Medical evaluation is recommended for all patients who experience severe hypoglycemia.

Use as a diagnostic aid

GlucaGen is indicated for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract. Glucagon is as effective for this examination as are the anticholinergic drugs. However, the addition of the anticholinergic agent may result in increased side effects. After the end of the diagnostic procedure, give oral carbohydrates to patients who have been fasting, if this is compatible with the diagnostic procedure applied.

DOSAGE AND ADMINISTRATION

For GlucaGen HypoKit

Treatment of severe hypoglycemia
  • Using the supplied prefilled syringe, carefully insert the needle through the rubber stopper of the vial containing GlucaGen powder and inject all the liquid from the syringe into the vial.
  • Shake the vial gently until the powder is completely dissolved and no particles remain in the fluid. The reconstituted fluid should be clear and of water-like consistency.
  • The reconstituted GlucaGen gives a concentration of approximately 1 mg/mL glucagon.
  • The reconstituted GlucaGen should be used immediately after reconstitution.
  • Inject 1 mL (adults and children, weighing more than 55 lbs (25 kg)) or 0.5 mL (children weighing less than 55 lbs (25 kg)) subcutaneously, intramuscularly, or intravenously. If the weight is not known: children younger than 6 years should be given a 0.5 mL and children 6 years and older should be given 1 mL.
  • Discard any unused portion.
  • Emergency assistance should be sought immediately after subcutaneous or intramuscular injection of glucagon.
  • The glucagon injection may be repeated using a new kit while waiting for emergency assistance.
  • Intravenous glucose MUST be administered if the patient fails to respond to glucagon.
  • When the patient has responded to the treatment, give oral carbohydrates to restore the liver glycogen and prevent recurrence of hypoglycemia.

For GlucaGen Diagnostic Kit and the GlucaGen 10-pack

Use as a diagnostic aid
  1. GlucaGen should be reconstituted with 1 mL of Sterile Water for Reconstitution (if supplied) or 1 mL of Sterile Water for Injection, USP. Using a syringe, withdraw all of the Sterile Water for Reconstitution (if supplied) or 1 mL Sterile Water for Injection, USP and inject into the GlucaGen vial.
  2. Shake the vial gently until the powder is completely dissolved and no particles remain in the fluid. The reconstituted fluid should be clear and of water-like consistency.
  3. The reconstituted GlucaGen gives a concentration of approximately 1 mg/mL glucagon.
  4. The reconstituted GlucaGen should be used immediately after reconstitution.
  5. GlucaGen must be administered by medical personnel.
  6. Discard any unused portion.
  7. Onset of action after an injection will depend on the organ under examination and route of administration [see Pharmacodynamics].
  8. The usual diagnostic dose for relaxation of the stomach, duodenal bulb, duodenum, and GlucaGen must be administered by medical personnel. small bowel is 0.2 mg to 0.5 mg given intravenously or 1 mg given intramuscularly; the usual dose to relax the colon is 0.5 mg to 0.75 mg intravenously and 1 mg to 2 mg intramuscularly [see Pharmacodynamics].
  9. After the end of the diagnostic procedure, give oral carbohydrates to patients who have been fasting, if this is compatible with the diagnostic procedure applied.

The GlucaGen Diagnostic Kit and the GlucaGen 10-pack presentations are intended only for use by healthcare providers as a diagnostic aid. The GlucaGen Diagnostic Kit and the GlucaGen 10-pack presentations are not intended for use by patients to treat severe hypoglycemia because they are not packaged with a syringe and diluent necessary for rapid preparation and administration during an emergency outside of a healthcare facility.

HOW SUPPLIED

Dosage Forms And Strengths

GlucaGen is supplied in a vial, alone, or accompanied by Sterile Water for Reconstitution (1 mL) also in a vial (10 pack or diagnostic kit). It is also supplied as GlucaGen HypoKit®, a presentation with a disposable prefilled syringe containing 1 mL Sterile Water for Reconstitution. When the glucagon powder is reconstituted with Sterile Water for Reconstitution (if supplied) or with Sterile Water for Injection, USP, it forms a solution of 1 mg/mL (1 unit/mL) glucagon for subcutaneous, intramuscular, or intravenous injection.

Storage And Handling

How Supplied

GlucaGen is supplied as a sterile, lyophilized white powder in a vial, alone, or accompanied by Sterile Water for Reconstitution also in a vial (Diagnostic Kit or 10-pack). It is also supplied as GlucaGen HypoKit with a disposable prefilled syringe containing Sterile Water for Reconstitution.

GlucaGen HypoKit includes

1 vial containing 1 mg (1 unit) GlucaGen (glucagon [rDNA origin] for injection)

1 disposable syringe containing 1 mL Sterile Water for Reconstitution

NDC 0169-7065-15

GlucaGen Diagnostic Kit includes

1 vial containing 1 mg (1 unit) GlucaGen (glucagon [rDNA origin] for injection)

1 vial containing 1mL Sterile Water for Reconstitution

NDC 55390-004-01

The GlucaGen 10-pack includes

10 vials, each containing 1 mg (1 unit) GlucaGen (glucagon [rDNA origin] for injection)

NDC 55390-004-10

Recommended Storage

Before Reconstitution

The GlucaGen package may be stored up to 24 months at controlled room temperature 20o to 25o C (68o to 77o F) prior to reconstitution. Do not freeze. Keep in the original package to protect from light. GlucaGen should not be used after the expiry date on the vials.

After Reconstitution

Reconstituted GlucaGen should be used immediately. Discard any unused portion. If the solution shows any sign of gel formation or particles, it should be discarded.

Date of issue: 12/2011. For information contact: Novo Nordisk Inc. 100 College Road West, Princeton, NJ 08540, USA. 1-800-727-6500. www.novonordisk-us.com. Manufactured by: Novo Nordisk A/S 2880 Bagsvaerd, Denmark

Last reviewed on RxList: 1/13/2012
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Diabetes

Find tips and advances in treatment.